The deadline is rapidly approaching for pharmaceutical manufacturers to implement renewed vigilance for elemental impurities during drug production processes. Under the ICH Q3D guidelines that go into effect on January 1, 2018, manufacturers must test for the presence of 24 elemental impurities in medications. Although the guidelines do not address glass explicitly, pharmaceutical manufacturers may inadvertently…